The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis.

Podobne knjige/članki

• The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis.
  od: Barton, P, et al.
  Izdano: (2004)
• The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis
  od: P Barton, et al.
  Izdano: (2004-03-01)
• The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis - Introduction
  od: Barton, P, et al.
  Izdano: (2004)
• The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: A systematic review and economic evaluation
  od: Jobanputra, P, et al.
  Izdano: (2002)
• The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation.
  od: Jobanputra, P, et al.
  Izdano: (2002)